Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration

Keyphrases

• Serum Antibody 100%
• Antibody Concentration 100%
• Nasopharyngeal 100%
• Vaccine Administration 100%
• Pneumococcal Conjugate Vaccine 100%
• IgG Concentration 100%
• PCV7 44%
• Carriage Rate 22%
• 13-valent Pneumococcal Conjugate Vaccine (PCV13) 22%
• New Acquisition 22%
• Jewish 11%
• Trial Registration 11%
• Bedouin 11%
• Logistic Regression Model 11%
• Serotype-specific 11%
• Acquisition Rate 11%
• Herd Protection 11%

Immunology and Microbiology

• Antibody Blood Level 100%
• Serotype 100%
• Pneumococcal Vaccine 100%
• Herd 20%

Medicine and Dentistry

• Serotype 100%
• Pneumococcus Vaccine 100%
• Logistic Regression Analysis 20%
• Herd 20%